Livforsakringsbolaget Skandia’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-11,772
Closed -$2.16M 663
2021
Q2
$2.16M Buy
11,772
+1,200
+11% +$220K 0.13% 152
2021
Q1
$1.62M Hold
10,572
0.11% 169
2020
Q4
$1.65M Buy
10,572
+1,700
+19% +$266K 0.14% 138
2020
Q3
$1.02M Buy
8,872
+6,500
+274% +$744K 0.11% 167
2020
Q2
$266K Hold
2,372
0.03% 329
2020
Q1
$213K Buy
2,372
+800
+51% +$71.8K 0.03% 330
2019
Q4
$170K Sell
1,572
-1,000
-39% -$108K 0.02% 376
2019
Q3
$252K Hold
2,572
0.03% 363
2019
Q2
$337K Buy
2,572
+600
+30% +$78.6K 0.04% 293
2019
Q1
$267K Hold
1,972
0.04% 302
2018
Q4
$192K Hold
1,972
0.03% 327
2018
Q3
$274K Sell
1,972
-1,400
-42% -$195K 0.03% 334
2018
Q2
$419K Hold
3,372
0.04% 341
2018
Q1
$376K Hold
3,372
0.04% 352
2017
Q4
$403K Sell
3,372
-900
-21% -$108K 0.04% 342
2017
Q3
$599K Hold
4,272
0.05% 305
2017
Q2
$520K Hold
4,272
0.05% 328
2017
Q1
$518K Sell
4,272
-10,900
-72% -$1.32M 0.05% 324
2016
Q4
$1.86K Buy
15,172
+8,472
+126% +$1.04K 0.09% 230
2016
Q3
$729K Sell
6,700
-13,172
-66% -$1.43M 0.04% 526
2016
Q2
$2.32M Hold
19,872
0.1% 233
2016
Q1
$2.77M Hold
19,872
0.13% 174
2015
Q4
$3.79M Sell
19,872
-200
-1% -$38.2K 0.18% 125
2015
Q3
$3.14M Buy
20,072
+1,700
+9% +$266K 0.16% 123
2015
Q2
$3.32M Hold
18,372
0.16% 133
2015
Q1
$3.18M Sell
18,372
-4,500
-20% -$780K 0.16% 135
2014
Q4
$4.23M Sell
22,872
-5,900
-21% -$1.09M 0.2% 114
2014
Q3
$4.77M Hold
28,772
0.18% 131
2014
Q2
$4.5M Hold
28,772
0.16% 148
2014
Q1
$4.38M Buy
+28,772
New +$4.38M 0.16% 144